• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过蛋白质组学对结核分枝杆菌的最新认识及其对临床的影响。

Recent insights into Mycobacterium tuberculosis through proteomics and implications for the clinic.

机构信息

a Department of Biochemistry , National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR) , Agra , India.

b Medical Microbiology and Molecular Biology Laboratory , Interdisciplinary Biotechnology Unit, Aligarh Muslim University , Aligarh , India.

出版信息

Expert Rev Proteomics. 2019 May;16(5):443-456. doi: 10.1080/14789450.2019.1608185. Epub 2019 Apr 27.

DOI:10.1080/14789450.2019.1608185
PMID:31032653
Abstract

This review aimed at providing an update on the application of proteomics-based approaches to gain recent insights of Mycobacterium tuberculosis (M.tb) and its relevance to clinic. Proteomics and bioinformatics approaches helped in the identification and characterization of novel proteins. Studying M.tb, causative agent of tuberculosis (TB), at the proteomic level can contribute to the identification of proteins which can be considered as potential targets for developed drugs and can help us in better understanding the pathogen physiology. Areas covered: In this review we have presented a comprehensive literature pertaining to role of proteomics in understanding M.tb. We have also focused on how the development and advancement in technology in the field of proteomics has augmented the research and played a pivotal role in answering many unexplored questions. Lastly, the application of proteomics to clinic has also been discussed. Expert commentary: We envisage that proteomics has gained remarkable momentum over the years. Proteomics can play an important role in the discovery of biomarkers for TB and other diseases. Also, it can aid in development of effective vaccines and simple, rapid and cost-effective test for the diagnosis of TB which is crucial for the management and control of the disease.

摘要

本综述旨在提供基于蛋白质组学方法的最新应用,以深入了解结核分枝杆菌(M.tb)及其与临床的相关性。蛋白质组学和生物信息学方法有助于鉴定和描述新的蛋白质。在蛋白质组学水平上研究结核分枝杆菌(导致结核病的病原体)可以有助于鉴定可以被认为是潜在药物靶点的蛋白质,并帮助我们更好地了解病原体的生理学。涵盖领域:在本综述中,我们提出了一份关于蛋白质组学在理解 M.tb 中的作用的综合文献。我们还重点介绍了技术在蛋白质组学领域的发展和进步如何增强了研究,并在回答许多未探索的问题方面发挥了关键作用。最后,还讨论了蛋白质组学在临床中的应用。专家评论:我们预计,蛋白质组学多年来已经取得了显著的进展。蛋白质组学可以在结核病和其他疾病的生物标志物发现中发挥重要作用。此外,它可以帮助开发有效的疫苗,并为结核病的诊断提供简单、快速和具有成本效益的测试,这对于疾病的管理和控制至关重要。

相似文献

1
Recent insights into Mycobacterium tuberculosis through proteomics and implications for the clinic.通过蛋白质组学对结核分枝杆菌的最新认识及其对临床的影响。
Expert Rev Proteomics. 2019 May;16(5):443-456. doi: 10.1080/14789450.2019.1608185. Epub 2019 Apr 27.
2
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
3
Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography.通过一维凝胶电泳和电荷色谱法对耐药结核分枝杆菌进行蛋白质组学分析。
Arch Microbiol. 2017 Jan;199(1):9-15. doi: 10.1007/s00203-016-1267-8. Epub 2016 Jul 14.
4
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
5
[Recent progress in mycobacteriology].[分枝杆菌学的最新进展]
Kekkaku. 2007 Oct;82(10):783-99.
6
Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.通过消减基因组学方法鉴定和表征广泛耐药结核分枝杆菌(XDR KZN 605)中假定蛋白的潜在药物靶点。
Eur J Pharm Sci. 2018 Mar 1;114:13-23. doi: 10.1016/j.ejps.2017.11.014. Epub 2017 Nov 22.
7
Impact of proteomics on anti-Mycobacterium tuberculosis (MTB) vaccine development.蛋白质组学对抗结核分枝杆菌(MTB)疫苗开发的影响。
Pol J Microbiol. 2009;58(4):281-7.
8
Prospective on Mycobacterium tuberculosis proteomics.结核分枝杆菌蛋白质组学展望。
J Proteome Res. 2012 Jan 1;11(1):17-25. doi: 10.1021/pr2008658. Epub 2011 Oct 19.
9
Tuberculosis结核病
10
Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant.一名肺结核患者从药物敏感型转变为耐多药型过程中结核分枝杆菌连续分离株的比较蛋白质组学分析
Indian J Med Res. 2015 Jan;141(1):27-45. doi: 10.4103/0971-5916.154492.

引用本文的文献

1
Model systems to study infections: an overview of scientific potential and impediments.用于研究感染的模型系统:科学潜力与障碍概述
Front Cell Infect Microbiol. 2025 May 8;15:1572547. doi: 10.3389/fcimb.2025.1572547. eCollection 2025.
2
Olink proteomics and lipidomics analysis of serum from patients infected with non-tuberculous mycobacteria and Mycobacterium tuberculosis.非结核分枝杆菌和结核分枝杆菌感染患者血清的 Olink 蛋白质组学和脂质组学分析。
Inflamm Res. 2024 Nov;73(11):1945-1960. doi: 10.1007/s00011-024-01943-z. Epub 2024 Sep 28.
3
Multi-omics-based characterization of the influences of Mycobacterium tuberculosis virulence factors EsxB and PPE68 on host cells.
基于多组学的结核分枝杆菌毒力因子 EsxB 和 PPE68 对宿主细胞影响的研究。
Arch Microbiol. 2023 May 10;205(6):230. doi: 10.1007/s00203-023-03576-y.
4
Mass Spectrometry-Based Proteomic and Metabolomic Profiling of Serum Samples for Discovery and Validation of Tuberculosis Diagnostic Biomarker Signature.基于质谱的血清蛋白质组学和代谢组学分析发现和验证结核病诊断生物标志物特征。
Int J Mol Sci. 2022 Nov 8;23(22):13733. doi: 10.3390/ijms232213733.
5
Tuberculous Granuloma: Emerging Insights From Proteomics and Metabolomics.结核性肉芽肿:蛋白质组学和代谢组学的新见解
Front Neurol. 2022 Mar 21;13:804838. doi: 10.3389/fneur.2022.804838. eCollection 2022.
6
Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort.基于 NMR 代谢组学的血清生物标志物发现用于结核病诊断,包括与第二队列的交叉验证。
Biomed J. 2022 Aug;45(4):654-664. doi: 10.1016/j.bj.2021.07.006. Epub 2021 Jul 24.
7
Insights into Proteomics and Biomarkers-An Overview.蛋白质组学与生物标志物洞察——概述
Proteomes. 2021 Jan 29;9(1):7. doi: 10.3390/proteomes9010007.
8
Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention.基于纳米的抗结核药物传递:改善治疗干预的新兴范例。
Drug Deliv Transl Res. 2020 Aug;10(4):1111-1121. doi: 10.1007/s13346-020-00786-5.